131 related articles for article (PubMed ID: 18795083)
1. The influence of estradiole and tibolone administration on leptin levels in women with surgically induced menopause.
Petzel M; Stejskal D; Jedelsky L; Kadalova L; Safarcik K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):101-5. PubMed ID: 18795083
[TBL] [Abstract][Full Text] [Related]
2. Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy.
Bednarek-Tupikowska G; Filus A; Kuliczkowska-Płaksej J; Tupikowski K; Bohdanowicz-Pawlak A; Milewicz A
Gynecol Endocrinol; 2006 Apr; 22(4):207-12. PubMed ID: 16723307
[TBL] [Abstract][Full Text] [Related]
3. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
[TBL] [Abstract][Full Text] [Related]
4. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
5. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
[TBL] [Abstract][Full Text] [Related]
6. The effect of different preparations of hormone therapy on tumor necrosis factor-alpha levels in women with surgical menopause.
Somunkiran A; Coskun A; Demirci F; Yucel O
Gynecol Endocrinol; 2008 Feb; 24(2):79-83. PubMed ID: 18210330
[TBL] [Abstract][Full Text] [Related]
7. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
[TBL] [Abstract][Full Text] [Related]
8. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
Ziaei S; Moghasemi M; Faghihzadeh S
Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
[TBL] [Abstract][Full Text] [Related]
10. Effects of transdermal estradiol gel and oral tibolone on health-related quality of life after surgical menopause.
Bhattacharya SM; Jha A
Int J Gynaecol Obstet; 2010 Sep; 110(3):213-6. PubMed ID: 20570264
[TBL] [Abstract][Full Text] [Related]
11. Effects of bilateral ovariectomy and estrogen replacement therapy on serum leptin, sex hormone binding globulin and insulin like growth factor-I levels.
Nar A; Demirtas E; Ayhan A; Gurlek A
Gynecol Endocrinol; 2009 Dec; 25(12):773-8. PubMed ID: 19905995
[TBL] [Abstract][Full Text] [Related]
12. The effect of tibolone versus 17beta-estradiol on climacteric symptoms in women with surgical menopause: a randomized, cross-over study.
Somunkiran A; Erel CT; Demirci F; Senturk ML
Maturitas; 2007 Jan; 56(1):61-8. PubMed ID: 16831525
[TBL] [Abstract][Full Text] [Related]
13. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
Lambrinoudaki IV; Christodoulakos GE; Economou EV; Vlachou SA; Panoulis CP; Alexandrou AP; Kouskouni EE; Creatsas GC
Maturitas; 2008 Jan; 59(1):62-71. PubMed ID: 18164562
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women.
Castelo-Branco C; Vicente JJ; Figueras F; Sanjuan A; Martínez de Osaba MJ; Casals E; Pons F; Balasch J; Vanrell JA
Maturitas; 2000 Feb; 34(2):161-8. PubMed ID: 10714911
[TBL] [Abstract][Full Text] [Related]
15. Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women.
Dedeoğlu EN; Erenus M; Yörük P
Fertil Steril; 2009 Feb; 91(2):425-31. PubMed ID: 18249383
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of tibolone and transdermal estrogen therapy on psychological symptoms in women following surgical menopause.
Baksu A; Ayas B; Citak S; Kalan A; Baksu B; Goker N
Int J Gynaecol Obstet; 2005 Oct; 91(1):58-62. PubMed ID: 15970290
[TBL] [Abstract][Full Text] [Related]
17. Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause.
Perrone G; Capri O; Galoppi P; Brunelli R; Bevilacqua E; Ceci F; Ciarla MV; Strom R
Gynecol Obstet Invest; 2009; 68(1):33-9. PubMed ID: 19349712
[TBL] [Abstract][Full Text] [Related]
18. [Circulating leptin doesn not change in postmenopausal women receiving replacement therapy with tibolone].
Basurto L; Galván R; Ochoa R; Fonseca E; Zárate A
Ginecol Obstet Mex; 2000 Oct; 68():416-9. PubMed ID: 11138402
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
Tommaselli GA; Di Carlo C; Di Spiezio Sardo A; Bifulco G; Cirillo D; Guida M; Capasso R; Nappi C
Menopause; 2006; 13(4):660-8. PubMed ID: 16837888
[TBL] [Abstract][Full Text] [Related]
20. Effect of different hormonal therapies on thyroid function in surgical menopause: short-term results.
Erel CT; Gezer A; Sentürk LM; Somunkiran A; Kaleli S; Seyisoglu H
J Reprod Med; 2007 Dec; 52(12):1079-84. PubMed ID: 18210897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
